The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Accelerating sustainability in Indian pharma industry
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
